BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31646782)

  • 1. Surgery versus external beam radiation therapy for AJCC stage I hepatocellular carcinoma.
    Han B; Shao L; Li C; Xu Y; Tang Y; Han L; Qi X
    J BUON; 2019; 24(4):1390-1401. PubMed ID: 31646782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion.
    McGee HM; King MJ; Ă–zbek U; Olson A; Kim E; Fischman AM; Schwartz M; Rosenzweig KE; Buckstein M
    Am J Clin Oncol; 2019 Apr; 42(4):367-374. PubMed ID: 30724782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of treatment modalities for hepatocellular carcinoma at stages T1 and T2: A preliminary analysis based on the Surveillance, Epidemiology, and End Results registry database.
    Han B; Yao H; Shao L; Guo X; Han L; Gomes Romeiro F; Mancuso A; Qi X
    J BUON; 2018; 23(3):611-621. PubMed ID: 30003727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic difference between surgery and external radiation in patients with stage I liver cancer based on competitive risk model and conditional survival rate.
    Chen R; An Y; Xu M
    PLoS One; 2024; 19(3):e0298014. PubMed ID: 38547200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study.
    Chen L; Sun T; Chen S; Ren Y; Yang F; Zheng C
    World J Surg Oncol; 2020 Jun; 18(1):119. PubMed ID: 32487104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of survival between adolescent and young adult
    Ren J; Tong YM; Cui RX; Wang Z; Li QL; Liu W; Qu K; Zhang JY; Liu C; Wan Y
    World J Gastrointest Oncol; 2020 Dec; 12(12):1394-1406. PubMed ID: 33362910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
    Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
    J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of radiofrequency ablation versus cryoablation in the treatment of single hepatocellular carcinoma: A population-based study.
    Chen L; Ren Y; Sun T; Cao Y; Yan L; Zhang W; Ouyang T; Zheng C
    Cancer Med; 2021 Jun; 10(11):3715-3725. PubMed ID: 33960697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.
    Zeng ZC; Fan J; Tang ZY; Zhou J; Qin LX; Wang JH; Sun HC; Wang BL; Zhang JY; Jiang GL; Wang YQ
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):432-43. PubMed ID: 15667964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database.
    Berger NG; Tanious MN; Hammad AY; Miura JT; Mogal H; Clarke CN; Christians KK; Tsai S; Gamblin TC
    J Surg Oncol; 2017 Sep; 116(3):307-312. PubMed ID: 28464313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database.
    Lin Q; Huang X; Zhong C; Luo T; Zeng X; Chen S
    Cancer Med; 2019 Feb; 8(2):515-526. PubMed ID: 30656831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
    Gou XX; Shi HY; Li C; Chen ZL; Ouyang W; Sun LY; Diao YK; Wang MD; Yao LQ; Gu LH; Pawlik TM; Lau WY; Shen F; Xue J; Yang T
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):238-249. PubMed ID: 35643251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma.
    Yoon HI; Jung I; Han KH; Seong J
    Oncotarget; 2016 Sep; 7(38):62715-62725. PubMed ID: 27486881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
    Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
    BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
    Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
    J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
    J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
    Lin H; Li X; Liu Y; Hu Y
    ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target population.
    Han B; Li C; Meng H; Gomes Romeiro F; Mancuso A; Zhou Z; Levi Sandri GB; Xu Y; Han T; Han L; Shao L; Qi X
    Biosci Trends; 2019 Mar; 13(1):10-22. PubMed ID: 30799321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis.
    Wu JY; Sun JX; Wu JY; Huang XX; Bai YN; Wei YG; Zhang ZB; Zhou JY; Cheng SQ; Yan ML
    Ann Surg Oncol; 2022 Feb; 29(2):949-958. PubMed ID: 34591226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis.
    Wu L; Tsilimigras DI; Farooq A; Hyer JM; Merath K; Paredes AZ; Mehta R; Sahara K; Shen F; Pawlik TM
    Cancer; 2019 Nov; 125(21):3767-3775. PubMed ID: 31299092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.